Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Nantahala Capital Management, LLC 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Nantahala Capital Management, LLC (CIK 1472322) reported $3.01B across 132 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: IWM ($600.9M, 19.93%), PTON ($127.3M, 4.22%), HGV ($110.4M, 3.66%), HLF ($101.4M, 3.36%), TBBK ($85.5M, 2.84%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1IWMISHARES TR$600.9M19.93%2.0MTrimmed
2PTONPELOTON INTERACTIVE INC$127.3M4.22%21.5MTrimmed
3HGVHILTON GRAND VACATIONS INC$110.4M3.66%2.1MTrimmed
4HLFHERBALIFE LTD$101.4M3.36%7.7MAdded
5TBBKBANCORP INC DEL$85.5M2.84%1.4MTrimmed
6VTRSVIATRIS INC$79.4M2.63%5.0MHold
7EWEDWARDS LIFESCIENCES CORP$72.4M2.40%800,000Hold
8QUREUNIQURE NV$65.3M2.17%1.4MTrimmed
9XBISPDR SERIES TRUST$63.3M2.10%400,000Added
10BVSBIOVENTUS INC$56.6M1.88%6.0MTrimmed
11SVRASAVARA INC$43.0M1.43%7.0MTrimmed
12ETONETON PHARMACEUTICALS INC$42.6M1.41%1.2MHold
13AMRXAMNEAL PHARMACEUTICALS INC$39.3M1.30%2.3MTrimmed
14EOLSEVOLUS INC$38.9M1.29%5.6MTrimmed
15ABEOABEONA THERAPEUTICS INC$38.0M1.26%6.2MAdded
16QTUMETF SER SOLUTIONS$36.9M1.22%223,000New
17FOXFFOX FACTORY HLDG CORP$35.8M1.19%2.1MTrimmed
18CWHCAMPING WORLD HLDGS INC$34.7M1.15%4.6MTrimmed
19AVTXAVALO THERAPEUTICS INC$34.4M1.14%1.9MAdded
20LBRXLB PHARMACEUTICALS INC$34.2M1.13%1.1MHold
21NBIXNEUROCRINE BIOSCIENCES INC$33.7M1.12%200,000New
22AVRANTERIS TECHNOLOGIES GLOBAL$33.3M1.11%3.4MTrimmed
23PRAXPRAXIS PRECISION MEDICINES I$33.5M1.11%100,000New
24RDNWRIDENOW GROUP INC$33.1M1.10%5.0MHold
25KRYSKRYSTAL BIOTECH INC$31.6M1.05%85,000New

Source: SEC Form 13F filings · as of 2026-06-30